St. Jude Children's Research Hospital is dedicated to improving the treatment of children with catastrophic illnesses, with a primary focus on cancer treatment and research. Investigators at St. Jude Children's Cancer Center are dedicated to the discovery of basic biological mechanisms in cancer pathogenesis and to improving the diagnosis and treatment for childhood cancers. Our scientists and physicians, whether engaged in discovery oriented, laboratory research or patient-focused clinical investigation, share a common dedication to improving the treatment and cure of children with cancer. Areas of strength in our Cancer Center include investigations of fundamental cell processes such as transcriptional regulation, cell signal transduction, and cell cycle control, elucidation of molecular mechanisms of oncogenesis including chromosomal translocations and tumor suppressor gene inactivation, molecular analysis of drug action, evaluation of innovative treatment strategies and the development of new therapeutic modalities. Hallmarks of our multidisciplinary research programs include a strong foundation of discovery-oriented, investigator-initiated research, and successful interactions among basic scientists and clinical investigators to translate new findings into innovative treatments to improve the outcomes of children with cancer. St. Jude Children's Cancer Center comprises six established programs (Signal Transduction, Hematological Malignancies, Molecular Oncogenesis, Solid Malignancies, Transplantation and Gene Therapy, and Viral Oncogenesis and Tumor Immunology) and two developing programs (Neurobiology and Brain Tumors, and Cancer Prevention and Control), supported by 18 Shared Resources that facilitate multidisciplinary research among our 141 Cancer Center members. As the only NCI-sponsored Cancer Center devoted solely to cancer in children, St. Jude is uniquely positioned to integrate basic and clinical research to elucidate the mechanisms and improve the treatment of childhood cancers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA021765-21S1
Application #
2867371
Study Section
Subcommittee G - Education (NCI)
Project Start
1977-09-01
Project End
2002-02-28
Budget Start
1998-03-18
Budget End
1999-02-28
Support Year
21
Fiscal Year
1998
Total Cost
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Stewart, Elizabeth; McEvoy, Justina; Wang, Hong et al. (2018) Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic Analyses. Cancer Cell 34:411-426.e19
Broniscer, Alberto; Hwang, Scott N; Chamdine, Omar et al. (2018) Bithalamic gliomas may be molecularly distinct from their unilateral high-grade counterparts. Brain Pathol 28:112-120
Wogksch, Matthew D; Howell, Carrie R; Wilson, Carmen L et al. (2018) Physical fitness in survivors of childhood Hodgkin lymphoma: A report from the St. Jude Lifetime Cohort. Pediatr Blood Cancer :e27506
Nishii, Rina; Moriyama, Takaya; Janke, Laura J et al. (2018) Preclinical evaluation of NUDT15-guided thiopurine therapy and its effects on toxicity and antileukemic efficacy. Blood 131:2466-2474
Fernandez-Pineda, Israel; Davidoff, Andrew M; Lu, Lu et al. (2018) Impact of ovarian transposition before pelvic irradiation on ovarian function among long-term survivors of childhood Hodgkin lymphoma: A report from the St. Jude Lifetime Cohort Study. Pediatr Blood Cancer 65:e27232
Vanarotti, Murugendra; Evison, Benjamin J; Actis, Marcelo L et al. (2018) Small-molecules that bind to the ubiquitin-binding motif of REV1 inhibit REV1 interaction with K164-monoubiquitinated PCNA and suppress DNA damage tolerance. Bioorg Med Chem 26:2345-2353
Quinn, Melissa; Fannin, J T; Sciasci, Joseph et al. (2018) Pentamidine for Prophylaxis against Pneumocystis jirovecii Pneumonia in Pediatric Oncology Patients Receiving Immunosuppressive Chemotherapy. Antimicrob Agents Chemother 62:
Halalsheh, Hadeel; Kaste, Sue C; Navid, Fariba et al. (2018) The role of routine imaging in pediatric cutaneous melanoma. Pediatr Blood Cancer 65:e27412
Wang, Lu; Hiler, Daniel; Xu, Beisi et al. (2018) Retinal Cell Type DNA Methylation and Histone Modifications Predict Reprogramming Efficiency and Retinogenesis in 3D Organoid Cultures. Cell Rep 22:2601-2614
Wang, Xusheng; Jones, Drew R; Shaw, Timothy I et al. (2018) Target-Decoy-Based False Discovery Rate Estimation for Large-Scale Metabolite Identification. J Proteome Res 17:2328-2334

Showing the most recent 10 out of 6764 publications